Pnc Financial Services Group, Inc. Tarsus Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 208 shares of TARS stock, worth $8,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
208
Previous 210
0.95%
Holding current value
$8,525
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.5MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$136 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$134 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$107 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$102 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$101 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.09B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...